Cancer researchers warn US budget cuts block advances

June 1, 2013

Cancer researchers warned Friday that federal budget cuts enacted by the US Congress could block key advances in the fight against deadly disease.

"Draconian cuts to biomedical research will slow our progress at the moment of greatest scientific potential and increasing need worldwide," Dr. Sandra Swain, president of the , said at the opening of the group's annual meeting.

The National Institutes of Health's budget has been slashed by 20 percent and is now at its lowest level since 2001, Swain said.

That funding needs to be restored if researchers are going to be able to expand on the significant progress made in recent years developing new treatments and diagnostic tools.

More than 7.6 million people worldwide will die from cancer this year and that number is expected to rise to over 12 million by 2030.

In addition to undermining more , the cuts could also limit the number of able to participate in clinical trials which could extend their lives.

"Even before the most recent budget cuts our clinical research didn't have the strong federal funding it needed," Swain told reporters.

"Our federally funded clinical trials system has achieved remarkable advances that have improved survival and quality of life for millions of people with cancer, but this progress is occurring under the cloud of slashing."

Public spending on US clinical trials for come in at around $243 million a year while pharmaceutical companies spend $6 billion, said Monica Bertagnolli, chair of the Alliance for Clinical Trials in Oncology.

" is not just drugs," Bertagnolli said, warning that important but "unprofitable" areas of research are not being sufficiently pursued.

Some 30,000 cancer specialists are expected to attend the society's annual meeting in Chicago, where over 4,700 studies will be presented.

Explore further: Cancer patients may be unintended victims of budget cuts

Related Stories

Cancer patients may be unintended victims of budget cuts

April 4, 2013
(HealthDay)—Thousands of Medicare cancer patients are being denied treatment at clinics nationwide because of federal budget cuts related to the so-called sequester, according to a published report.

Budget cuts could slow commercial space progress

March 28, 2013
The head of NASA says federal spending cuts could eventually slow progress on commercial efforts to fly to space.

New therapy is tolerable in lung cancer

May 31, 2013
A promising new therapy for the most common form of lung cancer appears to produce largely manageable side effects, and an ongoing clinical trial is determining whether the compound treats tumors more effectively than what's ...

The value of randomized clinical trials in radiation oncology clinical practice

May 29, 2013
Cancer patients, physicians and insurers want to be sure that whatever therapy is recommended and provided to patients is based on evidence, preferably results from randomized clinical trials. But are there enough clinical ...

American Society of Clinical Oncology issues annual report on state of clinical cancer science

December 3, 2012
The American Society of Clinical Oncology (ASCO) has just released its annual report on the top cancer advances of the year. Clinical Cancer Advances 2012: ASCO's Annual Report on Progress Against Cancer, highlights major ...

Recommended for you

Study provides insight into link between two rare tumor syndromes

August 22, 2017
UCLA researchers have discovered that timing is everything when it comes to preventing a specific gene mutation in mice from developing rare and fast-growing cancerous tumors, which also affects young children. This mutation ...

Retaining one normal BRCA gene in breast, ovarian cancers influences patient survival

August 22, 2017
Determining which cancer patients are likely to be resistant to initial treatment is a major research effort of oncologists and laboratory scientists. Now, ascertaining who might fall into that category may become a little ...

Clear link between heavy vitamin B intake and lung cancer

August 22, 2017
New research suggests long-term, high-dose supplementation with vitamins B6 and B12—long touted by the vitamin industry for increasing energy and improving metabolism—is associated with a two- to four-fold increased lung ...

Study identifies miR122 target sites in liver cancer and links a gene to patient survival

August 22, 2017
A new study of a molecule that regulates liver-cell metabolism and suppresses liver-cancer development shows that the molecule interacts with thousands of genes in liver cells, and that when levels of the molecule go down, ...

Zebrafish larvae could be used as 'avatars' to optimize personalized treatment of cancer

August 21, 2017
Portuguese scientists have for the first time shown that the larvae of a tiny fish could one day become the preferred model for predicting, in advance, the response of human malignant tumors to the various therapeutic drugs ...

Scientists discover vitamin C regulates stem cell function, curbs leukemia development

August 21, 2017
Not much is known about stem cell metabolism, but a new study from the Children's Medical Center Research Institute at UT Southwestern (CRI) has found that stem cells take up unusually high levels of vitamin C, which then ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

Shootist
1 / 5 (1) Jun 01, 2013
Cancer researchers warn US budget cuts block advances

Uh, then get the Canadians to pay for it. Or the British, Russians and Germans.

America isn't the only rich tasting teat in the barnyard.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.